As of Jul 29
| -0.031 / -3.37%|
The 3 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 4.00 and a low estimate of 1.00. The median estimate represents a +237.08% increase from the last price of 0.89.
The current consensus among 3 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.